Aliada Therapeutics
Beyond boundaries: Crossing the blood-brain barrier to create the next generation of central nervous system therapies
26 employees · est. 2021 · Boston, United States
NsGene A/S is the older company (2021 vs 1999).
Side-by-Side Comparison
| Metric | Aliada Therapeutics | NsGene A/S |
|---|---|---|
| Founded | ||
| Founded | 2021 | 1999 older |
| Headquarters | ||
| Headquarters | Boston, United States | Not tracked yet |
| Employees | ||
| Employees | 26 | 13 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Series Unknown | Grant |
| Total Funding | ||
| Total Funding | $32.00M | $5.69M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biologics, CNS Drug Development, Blood-brain Barrier Crossing, Therapeutic Antibodies, NHP Proof Of Concept, Oligonucleotide Delivery, Central Nervous System Therapies, Preclinical Evaluation, Platform Technology, Enzyme Therapy, Customizable Delivery Technology | Biotech, Neurological Diseases, Alzheimer's Disease, Parkinson's Disease, Sensorineural Hearing Loss, Therapeutic Macromolecules, Drug Delivery Methods, EC Biodelivery, Medicon Valley, Danish Biotech Company, Epilepsy, Neuropathic Pain, Novel Biologics, Proprietary Technology, Unmet Medical Needs |
| Website | ||
| Website | aliadatx.com | nsgene.dk |
About Aliada Therapeutics
Aliada Therapeutics is a biotechnology startup that aims to revolutionize the treatment of central nervous system (CNS) diseases by overcoming the challenge of crossing the blood-brain barrier. With the slogan "Beyond boundaries: Crossing the blood-brain barrier to create the next generation of cent...
About NsGene A/S
NsGene A/S is a biopharmaceutical company founded in 1999, dedicated to developing innovative biological products for the treatment of neurological diseases, with a specific focus on Alzheimer's disease, Parkinson's disease, and sensorineural hearing loss. The company is leveraging its patented tech...
We will tell you when either one moves
BounceWatch watches Aliada Therapeutics and NsGene A/S for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aliada Therapeutics and NsGene A/S — by email.
Frequently Asked Questions
Compare Aliada Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Aliada Therapeutics on 4 Dec 2024, and NsGene A/S on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.